FDA Inspection 644313 — Celgene Corp., D.B.A. Abraxis BioScience LLC
The FDA completed an inspection of Celgene Corp., D.B.A. Abraxis BioScience LLC on Feb 8, 2010 in Melrose Park, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 8, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Melrose Park, IL (United States)